Vertical · Weight loss

Medical weight loss, without the sales pitch.

GLP-1 medications changed this category from willpower theater into actual medicine — and spawned an industry happy to prescribe to anyone with a card on file. Our coverage is the unglamorous version: how the medications work, what they genuinely cost over a year, the side effects nobody leads with, and which East Bay providers prescribe with an exam instead of a checkout flow.

SEMAGLUTIDE AND TIRZEPATIDE ARE PRESCRIPTION MEDICATIONS — A LICENSED CLINICIAN DECIDES WHETHER THEY'RE APPROPRIATE FOR YOU AFTER A REAL EVALUATION. NOTHING HERE IS MEDICAL ADVICE.

§ 01 — The medications

The guides, considered.

Semaglutide (GLP-1)A GLP-1 receptor agonist that slows gastric emptying and signals satiety. Branded as Wegovy for obesity and Ozempic for type 2 diabetes.TirzepatideA dual GIP/GLP-1 receptor agonist, branded Mounjaro for diabetes and Zepbound for obesity. The most effective FDA-approved weight-loss medication available.

§ 02 — By city

Providers who prescribe, near you.

Semaglutide in Dublin Semaglutide in Livermore Semaglutide in San Ramon Semaglutide in Walnut Creek Tirzepatide in Dublin Tirzepatide in Livermore Tirzepatide in Pleasanton Tirzepatide in San Ramon Tirzepatide in Walnut Creek

§ 03 — The concierge

Talk it through first.

Tell us what you're weighing and we'll connect you with a verified provider whose program starts with an evaluation, not a subscription — or tell you honestly what to read first.

Send a lead inquiry

Talk to a provider about medical weight loss.

First name *Last name

Email *

PhoneZIP *

Anything specific you'd like to mention

Provider contact (required)I'd like verified providers to contact me about my inquiry by email or phone. Required to send the request. Not consent to receive automated marketing.SMS opt-in (optional)Send me appointment reminders and a single text from verified providers confirming receipt. Standard rates apply. Reply STOP to opt out. You don't have to check this to send your inquiry.Editorial newsletter (optional)Send me YoungYou's Sunday letter — one email a week. No third parties, no provider promotions. Unsubscribe anytime.

By sending this, you agree to YoungYou's privacy policy and terms. We may share your inquiry with the provider you selected. See disclosures for how YoungYou is compensated.

The Letter

One considered email every Sunday.

What's new in aesthetics and longevity, what we're paying attention to, and which providers we've added — without the noise.

One considered email every Sunday. Unsubscribe anytime. We don't share your email.